Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 31 04:00PM ET
0.7256
Dollar change
+0.0288
Percentage change
4.13
%
Index- P/E- EPS (ttm)-0.35 Insider Own11.49% Shs Outstand227.17M Perf Week-3.25%
Market Cap185.54M Forward P/E- EPS next Y-0.11 Insider Trans-0.08% Shs Float226.31M Perf Month-17.05%
Income-72.55M PEG- EPS next Q-0.01 Inst Own48.82% Short Float2.45% Perf Quarter-37.98%
Sales141.56M P/S1.31 EPS this Y45.72% Inst Trans-9.84% Short Ratio3.64 Perf Half Y-39.03%
Book/sh0.38 P/B1.93 EPS next Y-133.04% ROA-21.83% Short Interest5.56M Perf Year34.20%
Cash/sh0.84 P/C0.86 EPS next 5Y1.00% ROE-65.09% 52W Range0.42 - 2.05 Perf YTD-8.50%
Dividend Est.- P/FCF- EPS past 5Y10.30% ROI-52.44% 52W High-64.60% Beta2.22
Dividend TTM- Quick Ratio3.09 Sales past 5Y134.88% Gross Margin92.00% 52W Low72.76% ATR (14)0.05
Dividend Ex-Date- Current Ratio3.09 EPS Y/Y TTM36.88% Oper. Margin-64.09% RSI (14)28.42 Volatility7.36% 5.57%
Employees449 Debt/Eq0.49 Sales Y/Y TTM98.71% Profit Margin-51.25% Recom1.80 Target Price3.06
Option/ShortYes / Yes LT Debt/Eq0.44 EPS Q/Q330.46% Payout- Rel Volume0.81 Prev Close0.70
Sales Surprise216.85% EPS Surprise191.32% Sales Q/Q2394.41% EarningsAug 12 BMO Avg Volume1.53M Price0.73
SMA20-12.02% SMA50-25.63% SMA200-35.65% Trades Volume1,230,935 Change4.13%
Date Action Analyst Rating Change Price Target Change
Jul-30-24Initiated H.C. Wainwright Buy $4
May-30-24Initiated Scotiabank Sector Outperform $3.15
Mar-24-23Initiated Bryan Garnier Buy $3.60
Jan-03-23Upgrade Guggenheim Neutral → Buy $5
Nov-09-22Upgrade Mizuho Neutral → Buy $9
May-28-21Initiated Barclays Underweight $4
Apr-22-20Initiated Mizuho Neutral $3
Aug-02-19Downgrade Guggenheim Buy → Neutral
May-31-19Initiated ROTH Capital Buy
May-30-19Resumed Citigroup Buy
Today 05:20PM
Sep-20-24 08:35AM
Sep-16-24 12:07PM
Aug-28-24 08:00AM
Aug-12-24 07:00AM
07:13AM Loading…
Aug-09-24 07:13AM
Aug-05-24 08:00AM
Aug-02-24 11:53AM
08:46AM
06:54AM
Aug-01-24 08:20PM
Jul-24-24 11:13PM
Jul-03-24 11:11AM
06:00AM
Jun-03-24 12:00PM
07:39AM Loading…
May-31-24 07:39AM
May-30-24 04:01PM
04:01PM
May-17-24 06:49AM
May-16-24 08:18AM
May-15-24 12:53PM
11:07AM
07:30AM
07:00AM
May-01-24 12:00PM
Apr-23-24 07:45AM
Apr-15-24 02:12PM
Apr-12-24 08:00AM
05:37AM
Mar-27-24 07:30PM
01:42PM Loading…
Mar-07-24 01:42PM
08:24AM
Mar-06-24 12:52PM
07:00AM
Feb-27-24 08:00AM
Feb-21-24 04:00PM
Feb-16-24 03:57AM
Feb-13-24 06:15PM
Jan-31-24 04:44PM
Jan-30-24 01:02PM
Jan-16-24 11:17AM
Jan-04-24 07:37AM
Dec-06-23 07:00AM
Nov-30-23 10:52AM
Nov-29-23 08:00AM
Nov-13-23 09:35AM
08:35AM
Nov-08-23 07:30AM
07:05AM
Nov-07-23 06:15PM
Oct-31-23 08:00AM
08:00AM
Oct-27-23 06:15PM
Oct-25-23 08:06AM
Oct-23-23 04:15AM
Sep-11-23 08:00AM
Aug-09-23 07:29AM
Aug-03-23 01:24PM
Jul-28-23 12:30PM
Jul-20-23 07:28AM
Jul-16-23 08:18PM
Jun-29-23 09:18AM
Jun-26-23 11:23AM
11:15AM
Jun-23-23 09:15AM
Jun-22-23 09:40AM
Jun-19-23 10:18AM
Jun-16-23 08:39AM
Jun-15-23 09:43AM
08:18AM
Jun-13-23 10:14AM
Jun-12-23 10:00AM
09:48AM
Jun-09-23 10:52AM
Jun-06-23 06:50AM
Jun-05-23 11:40AM
10:22AM
Jun-01-23 03:29PM
May-30-23 09:35AM
May-25-23 05:00PM
May-12-23 07:29AM
May-09-23 06:43AM
May-05-23 05:00AM
Apr-28-23 12:00PM
Apr-18-23 11:49AM
Apr-12-23 10:42AM
Apr-11-23 12:13PM
08:00AM
Mar-08-23 07:14AM
05:23AM
Mar-06-23 01:08PM
06:30AM
06:00AM
Feb-22-23 08:00AM
Feb-16-23 08:00AM
Jan-09-23 08:00AM
Jan-08-23 07:06AM
Dec-28-22 06:51AM
Dec-27-22 09:05AM
Dec-23-22 01:20PM
Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Piccina CintiaChief Commercial OfficerJun 18 '24Sale0.9324,53122,81438,293Jun 18 05:00 PM
Rawcliffe AdrianChief Executive OfficerJan 17 '24Sale0.6730,08020,24444,848Jan 17 05:31 PM
Rawcliffe AdrianChief Executive OfficerJan 16 '24Sale0.799,3047,35014,104Jan 17 05:31 PM
Norry ElliotChief Medical OfficerJan 17 '24Sale0.6718,27612,3007,785Jan 17 05:31 PM
Norry ElliotChief Medical OfficerJan 16 '24Sale0.792,2871,8073,363Jan 17 05:31 PM
Lunger JohnChief Patient Supply OfficerJan 17 '24Sale0.6718,11412,1917,785Jan 17 05:30 PM
Lunger JohnChief Patient Supply OfficerJan 16 '24Sale0.794,6813,6987,023Jan 17 05:30 PM
Bertrand William C JRChief Operating OfficerJan 17 '24Sale0.6718,90812,7257,785Jan 17 05:30 PM
Bertrand William C JRChief Operating OfficerJan 16 '24Sale0.794,6813,6987,023Jan 17 05:30 PM
Norry ElliotChief Medical OfficerJan 12 '24Sale0.857,7996,66111,841Jan 12 05:00 PM
Norry ElliotChief Medical OfficerJan 11 '24Sale0.844,0093,3546,104Jan 12 05:00 PM
Bertrand William C JRChief Operating OfficerJan 12 '24Sale0.855,2204,4587,874Jan 12 05:00 PM
Bertrand William C JRChief Operating OfficerJan 11 '24Sale0.844,0093,3546,104Jan 12 05:00 PM
Rawcliffe AdrianChief Executive OfficerJan 12 '24Sale0.8517,25714,73926,388Jan 12 05:00 PM
Rawcliffe AdrianChief Executive OfficerJan 11 '24Sale0.8411,9459,99418,395Jan 12 05:00 PM
Lunger JohnChief Patient Supply OfficerJan 12 '24Sale0.855,2204,4587,874Jan 12 05:00 PM
Lunger JohnChief Patient Supply OfficerJan 11 '24Sale0.844,0093,3546,104Jan 12 05:00 PM